Drugs / SB cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04451486 | Aug 2018 → Dec 2019 | — | Taipei Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SB cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04451486 ↗ |
| Known as | Small blood stem cells | “Small blood stem cells (SB cells), isolated from human peripheral blood, demonstrated the ability to benefit bone regeneration and osseointegration.” PMID 34215319 ↗ Jul 2021 |